학술논문
Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC).
Document Type
Journal Article
Author
Source
Subject
*NEOADJUVANT chemotherapy
*QUALITY of life
*RESEARCH protocols
*IRINOTECAN
*TREATMENT effectiveness
*SURGICAL excision
*CHEMORADIOTHERAPY
*
*
*
*
*
*
Language
ISSN
1471-2407
Abstract